Effects of fentanyl versus remifentanyl pretreatment on the QTc interval in patients undergo rapid sequence intubation

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20090923002496N12

Enrollment

Registered

2019-05-04

Start date

2019-04-21

Completion date

Unknown

Last updated

2019-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rapid sequence intubation/induction.

Interventions

Intervention 1: Intervention group: In pretreatment Phase of RSI a single dose of 1 micg/Kg of remifentanyl ( Hamlen- Germany) will be administrated intravenously. Intervention 2: Control group: In pr

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: patients need airway management by rapid sequence intubation/induction Age over 18 years

Exclusion criteria

Exclusion criteria: cardiovascular disease diabetes chronic hypertension hypersensitivity to fentanyl or remifentanyl intracranial injury drug poisoning

Design outcomes

Primary

Measure	Time frame
Corrected QT interval. Timepoint: Before administration of fentanyl or remifentanyl, 1 minute after administration and after laringoscory. Method of measurement: ECG.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHassan Soleimanpour

Tabriz University of Medical Sciences

soleimanpourh@tbzmed.ac.ir+98 41 3335 2078

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026